Many recent research studies have focused on finding the earliest signs of Autism Spectrum Disorders (ASD). These studies aim to help pediatricians diagnose kids at a younger age so they can get needed interventions as quickly as possible.
One early sign of an Autism Spectrum Disorder may be increased head size or rapid head growth. Brain imaging studies have shown that abnormal brain development beginning in the child’s first months may have a role in Autism Spectrum Disorders. This theory proposes that genetic defects in growth factors (which direct proper brain development) cause the brain abnormalities seen in ASD. It's possible that the child’s sudden, rapid head growth may be an early warning signal, and this can help in early diagnosis and treatment or possible prevention of Autism Spectrum Disorders.
Current studies on Autism Spectrum Disorder treatment are exploring many approaches, such as:
Current studies on Autism Spectrum Disorder treatment are exploring many approaches, such as:
- New social interventions that can be used in the classroom or other everyday settings
- An intervention moms and dads can follow to reduce and prevent Autism-related disability in kids at high risk for the disorder
- A medication that may help improve functioning in kids with Fragile X syndrome
- A computer-based training program designed to teach kids with Autism Spectrum Disorders how to create and respond to facial expressions appropriately
For more information about clinical trials on Autism Spectrum Disorders, see “Featured Studies” below.
The Interagency Autism Coordinating Committee is a Federal advisory committee that coordinates all efforts within the Department of Health and Human Services concerning Autism Spectrum Disorders. Through its inclusion of both Federal and public members, the Interagency Autism Coordinating Committee helps to ensure that a wide range of ideas and perspectives are represented and discussed in a public forum.
The Interagency Autism Coordinating Committee mission is to:
- Facilitate the exchange of information on and coordination of Autism Spectrum Disorder activities among the member agencies and organizations
- Increase public understanding of the member agencies' activities, programs, policies, and research by providing a public forum for discussions related to Autism Spectrum Disorder research and services
- Provide advice to the Secretary of Health and Human Services regarding Federal activities related to Autism Spectrum Disorders
Interagency Autism Coordinating Committee meetings are open to the public and include presentations and discussions on a variety of topics (e.g., activities and projects of the Interagency Autism Coordinating Committee, recent advances in science and autism policy issues).
Featured Studies—
These studies include only those currently recruiting participants:
- A Study of the
Association Between Autism and Immune Changes in the Brain.
Evaluation study. Background: - People with autism and autism spectrum disorders have problems with communication, behavior, and socializing, and many also have intellectual and developmental disabilities. Ages 18-45. Location in Bethesda, MD. - Assessing Suicide
Risk in Adolescents With Developmental Delays.
Evaluation study. Background: - Currently, there is no standard method to study suicide risk in youth with developmental delays or intellectual disabilities (DD/ID). Ages 12-21. Location in Toronto, Canada. - Brain Imaging Study
of Adults With Autism Spectrum Disorders.
Interventional study. This research study investigates the effects of oxytocin and vasopressin on brain activity in adults with Autism Spectrum Disorders using functional magnetic resonance imaging (fMRI). Ages 18-40. Location in Bethesda, MD. - Clinical and
Immunological Investigations of Subtypes of Autism.
Evaluation study. The purpose of this study is to learn more about autism and its subtypes. Ages 1 year-6. Location in Bethesda, MD. - Cognitive
Neuroscience of Autism Spectrum Disorders.
Evaluation study. Background: - Autism spectrum disorders (Autism Spectrum Disorders) are a group of developmental disorders that affect communication, social interaction, and behavior. Ages 5-89. Location in Bethesda, MD. - Comparing
Parent-Implemented Interventions for Toddlers With Autism Spectrum
Disorders.
Interventional study. This study will compare the effectiveness of two parent-based programs for helping young kids at risk of autism. Ages 16 months-20 months. Locations in Tallahassee, FL; Ann Arbor, MI. - Effectiveness of
Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With
Autism.
Interventional study. This study will evaluate the effectiveness of atomoxetine in treating kids with attention deficit hyperactivity disorder symptoms associated with autistic disorder, Asperger's syndrome, and pervasive developmental disorder, not otherwise specified. Ages 5-15. Location in Indianapolis, IN. - Evaluating the
Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms
Associated With Autism.
Interventional study. This study will determine the effectiveness of aripiprazole and D-Cycloserine in treating symptoms associated with autism in kids. Ages 5-17. Location in Indianapolis, IN. - Identification of
Characteristics Associated With Symptom Remission in Autism.
Evaluation study. Autism is defined as a lifelong pervasive developmental disability, as such, symptom recovery is considered rare. Ages 7-17. Location in Bethesda, MD. - Long-Term Olanzapine
Treatment in Children With Autism.
Interventional study. This study will determine the short- and long-term safety and effectiveness of the drug olanzapine (Zyprexa®) for reducing symptoms of autism in kids. Ages 3-12. Location in Philadelphia, PA. - Methylphenidate for
Attention Deficit Hyperactivity Disorder and Autism in Children.
Interventional study. This study will first examine the cognitive and behavioral differences in kids who have an autism spectrum disorder (Autism Spectrum Disorder) and who do and do not have additional symptoms of attention deficit hyperactivity disorder (ADHD). Ages 7-12. Location in Houston, TX. - Screening for
Studies on Autism Spectrum Disorders.
Evaluation study. This study will screen kids and adolescents (and their parents) to determine the youngster's eligibility for participation in NIMH research studies on autism spectrum disorders, such as autism and Rett's Disorder. Ages up to 20. Location in Bethesda, MD. - Study of Toddlers
With Language Delay.
Evaluation study. The purpose of this study is to learn more about risk factors for autism by studying the behavior and brain functioning of toddlers with early communication delays and typically developing toddlers. Ages 10 months-20 months. Location in Bethesda, MD.
==> The Aspergers Comprehensive Handbook